В краткосрочни проучвания (7 дни) честотата на ендоскопски наблюдаваните гастро- дуоденални язви или ерозии при здрави млади и възрастни (> 65 години) пациенти, приели Dynastat, е 5- 21%.
In short-term studies (7 days), the incidence of endoscopically observed gastroduodenal ulcers or erosions in healthy young and elderly (≥ 65 years) subjects administered Dynastat (5-21%), although higher than placebo (5-12%), was statistically significantly lower than the incidence observed with NSAIDs (66-90%).